{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PPCB"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PPCB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","market":"US","secType":"STK","nameCN":"Propanc Biopharma, Inc.","latestPrice":4,"timestamp":1750449600000,"preClose":4,"halted":0,"volume":7005,"delay":15,"floatShares":11611800,"shares":11611800,"eps":-51.779603,"marketStatus":"Market Closed","change":0,"latestTime":"06-20 16:00:00 EDT Delay","open":4,"high":4,"low":4,"amount":28020.25,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-51.779603,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":4,"volumeRatio":3.3058048276331418},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","floatShares":11611800,"roa":"-298.55%","roe":"-767.20%","lyrEps":-1.798272,"volumeRatio":3.3058048276331418,"shares":11611800,"dividePrice":0,"high":4,"amplitude":0,"preClose":4,"low":4,"week52Low":0.0002,"pbRate":"2.57","week52High":102,"institutionHeld":0,"latestPrice":4,"eps":-51.779603,"divideRate":0,"volume":7005,"delay":15,"ttmEps":-51.779603,"open":4,"prevYearClose":0.0002,"prevWeekClose":8,"prevMonthClose":2.25,"prevQuarterClose":5.5,"fiveDayClose":8,"twentyDayClose":3.15,"sixtyDayClose":6.75},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PPCB\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPCB\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544183453","title":"Propanc Biopharma Secures New Financing with $25,000 Convertible Promissory Note and $13,188 AUD Loan for Working Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2544183453","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544183453?lang=en_us&edition=fundamental","pubTime":"2025-06-19 05:25","pubTimestamp":1750281934,"startTime":"0","endTime":"0","summary":"Propanc Biopharma Inc. has recently finalized two financing agreements to bolster its working capital. On June 12, 2025, the company entered into a securities purchase agreement with an investor, securing a convertible promissory note worth $25,000 for a purchase price of $22,500. The next day, Propanc also closed a loan agreement with a board member, obtaining an additional AUD 13,188. The loan bears an annual interest rate of 12%, payable monthly, with a default rate of 18%, and matures on June 30, 2025. Both agreements aim to support Propanc's general working capital needs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic D","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDLc31TVc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PPCB"],"gpt_icon":0},{"id":"2540715020","title":"Propanc Biopharma Secures $60,000 Promissory Note with Accredited Investor for Working Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2540715020","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540715020?lang=en_us&edition=fundamental","pubTime":"2025-06-03 05:30","pubTimestamp":1748899839,"startTime":"0","endTime":"0","summary":"Propanc Biopharma Inc. has entered into a new financing agreement, effective June 2, 2025, with an accredited investor. The company issued a Promissory Note with a principal amount of $60,000, purchased for $50,000, intended to bolster general working capital. The Note, maturing on July 15, 2025, carries a 10% annual interest rate. Propanc Biopharma has the option to repay the outstanding principal and accrued interest by July 7, 2025, or pay 120% of the principal if settled between July 7 and August 7, 2025. This agreement was made under a private placement exemption from registration.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the original content used to generate this news brief via EDGAR, the El","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL65mMyH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"gpt_icon":0},{"id":"2539270503","title":"Propanc announces offering of 1M shares of common stock, uplisting to Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2539270503","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539270503?lang=en_us&edition=fundamental","pubTime":"2025-05-31 03:50","pubTimestamp":1748634611,"startTime":"0","endTime":"0","summary":"Propanc Biopharma (PPCB) is offering 1M shares of common stock. The company is offering each share at an assumed public offering price of $5.00, wh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/propanc-announces-offering-of-1m-shares-of-common-stock-uplisting-to-nasdaq-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/propanc-announces-offering-of-1m-shares-of-common-stock-uplisting-to-nasdaq-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2210150020.SGD","NVIW.SI","IE00B64PRP62.GBP","PPCB","BK4585","QLD","MNQmain","USAW.SI","USJW.SI","IE00BGHQF748.EUR","LU2210149790.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","NQmain","NDAQ",".IXIC","QID","TQQQ","TSYW.SI","IE00BKPKM429.USD","PSQ","BK4588","BK4112","SQQQ"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPCB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-01-29","symbol":"PPCB","defaultRemindTime":1738161000000,"type":"split","dateTimestamp":1738126800000,"forFactor":60000,"toFactor":1,"ratio":60000},{"market":"US","date":"2023-05-23","symbol":"PPCB","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2020-11-19","symbol":"PPCB","defaultRemindTime":1605796200000,"type":"split","dateTimestamp":1605762000000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2019-06-24","symbol":"PPCB","type":"split","dateTimestamp":1561348800000,"forFactor":500,"toFactor":1,"ratio":500}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPCB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPCB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PPCB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PPCB","date":"2025-04-07","current":-0.048332,"percent":1,"low":-0.050633,"twenty":-0.050633,"median":-0.050633,"eighty":-0.049713,"high":-0.048332,"avg":-0.050058,"sd":0.000996,"marketCap":80703},"quantilePoints":[{"date":"2025-04-04","current":-0.050633,"twenty":-0.050633,"median":-0.050633,"eighty":-0.050633,"marketCap":84546},{"date":"2025-04-07","current":-0.048332,"twenty":-0.050633,"median":-0.050633,"eighty":-0.049713,"marketCap":80703}],"updateTime":1750479029486}}}